RECOMBINANT CNTF FOR TREATMENT OF NEUROPHATHIES
RECOMBINANT CNTF FOR TREATMENT OF NEUROPHATHIES
批准号:
3487947
负责人:
BARBARA L CORDELL
金额:
$5.0万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-02-01 至 1991-07-31
关键词:
DNA replication Escherichia coli ciliary ganglion complementary DNA gene expression genetic library genetic manipulation growth factor messenger RNA molecular cloning nervous system disorder neural degeneration neurogenesis neurotransmitter biosynthesis nucleic acid sequence parasympathetic nervous system peptide hormone peptide hormone metabolism polymerase chain reaction protein biosynthesis protein purification recombinant DNA transfection
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from applicant's abstract): Ciliary Neurotrophic
Factor (CNTF) is a potent polypeptide hormone whose actions appear to be
restricted to the nervous system. CNTF has been observed to promote
survival, parasympathetic neurotransmitter synthesis and neurite outgrowth
in various sympathetic, sensory and parasympathetic neurons at femtomolar
to low picomolar concentrations. Thus CNTF has potential clinical
applications in the treatment of a number of different neuropathies and
neurodegenerative disorders in man as well as in the treatment of traumatic
nerve injury. It is the goal of this project to assess this potential by
first providing a source of human CNTF using recombinant DNA methods (Phase
I) and then using this source to establish efficacy in specific acute
animal models of peripheral neuropathies (Phase II) and (if indicated) in
human clinical trials (Phase III).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ALZHEIMERS DISEASE INHIBITOR PROTEIN & COGNATE PROTEASE
-
批准号:2050614
-
项目类别:
-
资助金额:$24.66万
-
财政年份:1992
-
负责人:BARBARA L CORDELL
-
依托单位:
ALZHEIMERS DISEASE INHIBITOR PROTEIN & COGNATE PROTEASE
-
批准号:2050615
-
项目类别:
-
资助金额:$16.27万
-
财政年份:1992
-
负责人:BARBARA L CORDELL
-
依托单位:
TRANSGENIC MOUSE MODEL ALZHEIMER'S DISEASE AMYLOIDOSIS
-
批准号:3122583
-
项目类别:
-
资助金额:$11.79万
-
财政年份:1991
-
负责人:BARBARA L CORDELL
-
依托单位:
TRANSGENIC MOUSE MODEL ALZHEIMER'S DISEASE AMYLOIDOSIS
-
批准号:2051889
-
项目类别:
-
资助金额:$11.01万
-
财政年份:1991
-
负责人:BARBARA L CORDELL
-
依托单位:
TRANSGENIC MOUSE MODEL ALZHEIMER'S DISEASE AMYLOIDOSIS
-
批准号:2051890
-
项目类别:
-
资助金额:$11.38万
-
财政年份:1991
-
负责人:BARBARA L CORDELL
-
依托单位:
STRUCTURE/FUNCTION ALZHEIMERS DISEASE PROTEASE INHIBITOR
-
批准号:3487901
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1990
-
负责人:BARBARA L CORDELL
-
依托单位:
POTENTIAL BIOCHEMICAL DIAGNOSTIC FOR ALZHEIMERS DISEASE
-
批准号:3487705
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1988
-
负责人:BARBARA L CORDELL
-
依托单位:
HUMAN LUNG SURFACTANT DEFICIENCY DIAGNOSIS AND THERAPY
-
批准号:3499258
-
项目类别:
-
资助金额:$5.0万
-
财政年份:1985
-
负责人:BARBARA L CORDELL
-
依托单位:
国内基金
海外基金
登录
查看更多内容
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
-
批准号:32302245
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:潘寒姁
-
依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
-
批准号:82371775
-
项目类别:面上项目
-
资助金额:46万元
-
批准年份:2023
-
负责人:朱慧媛
-
依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
-
批准号:31871817
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:孙爱东
-
依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
-
批准号:81873549
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:刘玉兰
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的分子机制
-
批准号:31571933
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:廖小军
-
依托单位:
超高压诱导牛肉中Escherichia coli O157:H7亚致死损伤及其修复研究
-
批准号:31371861
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:江芸
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的机制
-
批准号:31371845
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:廖小军
-
依托单位:
高密度二氧化碳致死Escherichia coli的相关蛋白质确证及其结构变化研究
-
批准号:31171774
-
项目类别:面上项目
-
资助金额:66.0万元
-
批准年份:2011
-
负责人:张德权
-
依托单位: